Skip to main content

Closed

ALZN: Alzamend Neuro Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-1195.7%

Financially safe

Strong

Debt / equity0.00×

Interest coverage1324.5×

Current ratio1.31×

Alzamend Neuro Inc

ALZNNASDAQ·USD·Closed

Alzamend Neuro Inc

ALZNNASDAQ·USD·Closed

$1.31

−2.96%

$1.31

−$0.04 (2.96%)

52W Range

26thpctl

Volume

0.17×avg

Mkt Cap

4.98MUSD

P/E

-0.5TTM

Div Yield

–ann

52W Range

26thpctl

Volume

0.17×avg

Market Cap

4.98MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings